About SWORD Health
SWORD Health specializes in physical rehabilitation for musculoskeletal disorders (MSDs) through its product, the Digital Therapist. This platform combines technology with real physical therapists to guide patients through home-based rehabilitation exercises, providing real-time feedback for correct performance. By allowing patients to recover at home, SWORD Health reduces the need for clinic visits, making rehabilitation more convenient and cost-effective. The company aims to improve patient outcomes while delivering value to insurers and healthcare providers.
New York City, New YorkHeadquarters
2015Year Founded
$319.1MTotal Funding
SECONDARYCompany Stage
Consumer Software, HealthcareIndustries
501-1,000Employees
Benefits
A stimulating, fast-paced environment with lots of room for creativity
A bright future at a promising high-tech startup company
Career development and growth, with a competitive salary
The opportunity to work with a talented team and to add real value to an innovative solution with the potential to change the future of healthcare
A stimulating environment with room for creativity - fast-paced, fun, and energetic startup
A flexible environment where you can control your hours (remotely) with unlimited vacation
Access to our health and well-being program (digital therapist sessions)
Risks
Increased competition from platforms like Wellvolution may impact market share.
Dependency on Teladoc's client base could pose risks if partnership changes.
Rapid valuation increase may attract scrutiny if profitability targets aren't met.
Differentiation
Sword Health combines AI with physical therapists for effective MSD treatment.
The Digital Therapist offers real-time feedback, enhancing home-based rehabilitation.
Sword Health's AI Care platform is clinically rigorous and cost-effective.
Upsides
Partnership with Teladoc Health expands Sword Health's client base.
David Cohen's appointment as CRO supports strategic growth and revenue.
Phoenix AI assistant enhances patient engagement and therapy adherence.
Funding
Total raised$319.12 M
Latest valuation$3.00 B
StageSECONDARY
LATE VC
5/31/2024$30
$3.00 BSERIES B
1/31/2021$25
$125.00 MSERIES A
1/31/2020$10
$45.00 M$5
$23.00 MGRANT
6/30/2015$1